About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Updates in Malignant Pleural Mesothelioma
By
2023 Texas Lung Cancer Conference Coverage
FEATURING
Melina Marmarelis
By
2023 Texas Lung Cancer Conference Coverage
FEATURING
Melina Marmarelis
163 views
April 14, 2023
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
04:35
Total Health
Chemo vs. Chemo + Pembro in 1L Pleural Mesothelioma - 2023 ASCO® Dir…
Feat.
J. Bauman
15:37
ImmunoTherapy Bridge 2023
What’s New in NSCLC & Mesothelioma Immunotherapy
Feat.
A. Morabito
05:16
Scripps MD Anderson Cancer Center
Recent Updates on Chemo +/- IO in Mesothelioma
Feat.
R. Natale
07:11
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "First Survival Data From the NIPU Trial - …
Feat.
A. Helland
22:02
OncoAlert
Significant Advances in Mesothelioma
Feat.
G. Mountzios
09:04
Oncology Data Advisor
Discovering Research Advances in Mesothelioma
Feat.
S. Kareff,
E. Rodriguez
09:57
ILCC 2022 Conference Coverage
ILCC 2022 Mesothelioma: Updates in Systemic Therapy
Feat.
P. Baas
05:39
GRACE
ASCO® 2023 Insights: "Chemo +/- IO for Mesothelioma"
Feat.
J. West,
C. Lovly,
A. Addeo
05:22
ecancer
ESMO 2021 Updates on 1L Nivo+Ipi for Unresectable Malignant Pleural …
Feat.
S. Peters
04:33
ecancer
ASCO® 2023 Insights: "Pembro in 1L Treatment for Unresectable A…
Feat.
P. Bradbury
08:40
Laura Ridolfi
MESOVAX Clinical Trial of Pembro & Dendritic Cell Vaccine in Adv…
09:56
2020 Virtual ESMO Review
2020 ESMO Updates in Lung Cancer: Does 1L Nivolumab–Ipilimumab Boost…
Feat.
M. Dietrich
16:56
WCLC 2022 Conference Coverage
WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Ma…
Feat.
M. Jakopovic
17:52
Memorial Sloan Kettering Cancer Center
Malignant Pleural Mesothelioma: What Do Clinical Trials Suggest on A…
Feat.
M. Zauderer
21:36
2021 Virtual ESMO Review
ESMO 2021 Highlights on Stage III NSCLC and Malignant Mesothelioma: …
Feat.
T. Owonikoko
21:39
2021 Virtual ESMO Review
ESMO 2021 Q&A Panel Discussion on Lung Cancer
Feat.
I. Dagogo-Jack,
T. Owonikoko
05:47
GRACE
ASCO Roundtable on 2L Malignant Pleural Mesothelioma: How Encouragin…
Feat.
J. West,
H. Yu,
D. Spigel
07:16
WCLC 2022 Conference Coverage
WCLC 2022 on the Single Arm Phase II Study PEMMELA: Pembrolizumab + …
Feat.
L. Huaqing Douma
32:08
Olga Olevsky
Update on Mesothelioma: The Role of VEGF, Position of Immunotherapy,…
05:13
GRACE
Does Immunotherapy Have Activity in Malignant Pleural Mesothelioma?
Feat.
M. Das